European Immuno-Oncology Xchange 2021

December 1, 2021
Munich, Germany

Representative: Jamie Frankish, Ph.D., Head of Immunology

Presentation/Discussion Round at 9:05 am:
"HERA-Ligand platform as a next-generation agonistic approach in immuno-oncology"

Presentations and Posters from Past Conferences

AACR Virtual Annual Meeting II

June 22-24, 2020

Poster #4460:Novel bispecific molecules combining HERA-CD40L with anti-CEA or with anti-PD-L1 for targeting

Poster #4529: Neutralization of pro-apoptotic CD95L by Asunercept/APG101 does not impair anti-tumor immune responses

Presentation #1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies